| Literature DB >> 34140676 |
Chuck Haggerty1,2, Helene Kretzmer1, Christina Riemenschneider1,3, Abhishek Sampath Kumar1, Alexandra L Mattei1,4,5, Nina Bailly1, Judith Gottfreund6, Pay Giesselmann1, Raha Weigert1,3, Björn Brändl1,7, Pascal Giehr8, René Buschow9, Christina Galonska1,10, Ferdinand von Meyenn8, Melissa B Pappalardi11, Michael T McCabe11, Lars Wittler12, Claudia Giesecke-Thiel13, Thorsten Mielke9, David Meierhofer14, Bernd Timmermann15, Franz-Josef Müller1,7, Jörn Walter6, Alexander Meissner16,17,18,19.
Abstract
DNA methylation plays a critical role during development, particularly in repressing retrotransposons. The mammalian methylation landscape is dependent on the combined activities of the canonical maintenance enzyme Dnmt1 and the de novo Dnmts, 3a and 3b. Here, we demonstrate that Dnmt1 displays de novo methylation activity in vitro and in vivo with specific retrotransposon targeting. We used whole-genome bisulfite and long-read Nanopore sequencing in genetically engineered methylation-depleted mouse embryonic stem cells to provide an in-depth assessment and quantification of this activity. Utilizing additional knockout lines and molecular characterization, we show that the de novo methylation activity of Dnmt1 depends on Uhrf1, and its genomic recruitment overlaps with regions that enrich for Uhrf1, Trim28 and H3K9 trimethylation. Our data demonstrate that Dnmt1 can catalyze DNA methylation in both a de novo and maintenance context, especially at retrotransposons, where this mechanism may provide additional stability for long-term repression and epigenetic propagation throughout development.Entities:
Year: 2021 PMID: 34140676 DOI: 10.1038/s41594-021-00603-8
Source DB: PubMed Journal: Nat Struct Mol Biol ISSN: 1545-9985 Impact factor: 15.369